Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,368
Total Claims
$744K
Drug Cost
236
Beneficiaries
$3,152
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
+9%
Opioid rate vs peers
2.8% vs 2.6% avg
+155%
Cost per patient vs peers
$3,152 vs $1,237 avg
+109%
Brand preference vs peers
19.2% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.8%
Opioid Rate
261
Opioid Claims
$6,784
Opioid Cost
9.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,797 claims · $534K
Generic: 7,560 claims · $210K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 287 | $75K |
| Rifaximin | 28 | $50K |
| Dolutegravir Sodium/Lamivudine | 13 | $38K |
| Empagliflozin | 127 | $37K |
| Mirabegron | 163 | $36K |
| Exenatide Microspheres | 26 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 71 | $22K |
| Rivaroxaban | 82 | $21K |
| Dextromethorphan Hbr/Quinidine | 28 | $15K |
| Sacubitril/Valsartan | 35 | $12K |
| Insulin Detemir | 42 | $11K |
| Linaclotide | 16 | $8,828 |
| Memantine Hcl | 137 | $8,364 |
| Collagenase Clostridium Hist. | 12 | $7,877 |
| Duloxetine Hcl | 126 | $7,422 |
Prescribing Profile
Patient Profile
78
Avg Age
61%
Female
2.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About